THRESHOLD PHARMACEUTICALS IS A BIOPHARMACEUTICAL COMPANY DEDICATED TO THE DEVELOPMENT OF TUMOR-TARGETED MEDICINES TO IMPROVE THE LIVES OF INDIVIDUALS WITH CANCER.

We are a clinical-stage biopharmaceutical company using our expertise in the tumor microenvironment to develop therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. We are currently developing two therapeutic product candidates: evofosfamide and TH-3424